Xencor, Inc. (XNCR)
24.63
+0.13
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
24.59
-0.04
(-0.16%)
After-Hours: 20:00
Xencor Gross Profit Margin (Quarterly) : 95.24% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.24% |
| March 31, 2026 | 43.16% |
| December 31, 2025 | 90.87% |
| September 30, 2025 | 87.62% |
| June 30, 2025 | 93.92% |
| March 31, 2025 | 91.77% |
| December 31, 2024 | 94.33% |
| September 30, 2024 | 71.48% |
| June 30, 2024 | 82.17% |
| March 31, 2024 | 76.30% |
| December 31, 2023 | 92.78% |
| September 30, 2023 | 94.69% |
| June 30, 2023 | 93.66% |
| March 31, 2023 | 88.16% |
| December 31, 2022 | 90.01% |
| September 30, 2022 | 91.80% |
| June 30, 2022 | 92.63% |
| March 31, 2022 | 97.45% |
| December 31, 2021 | 98.63% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 94.83% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00% |
| September 30, 2017 | |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 88.29% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 99.60% |
| UroGen Pharma Ltd. | 90.93% |
| MeiraGTx Holdings Plc | 96.89% |
| IDEAYA Biosciences, Inc. | 87.21% |
| Iovance Biotherapeutics, Inc. | 46.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.16% |
| Return on Assets | -19.99% |
| Return on Invested Capital | -21.22% |
| Profit Margin (Quarterly) | -42.42% |
| Operating Margin (Quarterly) | -72.37% |
| Return on Net Operating Assets | -126.0% |